Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Canada.
Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Canada.
JACC Clin Electrophysiol. 2017 Sep;3(9):1046-1053. doi: 10.1016/j.jacep.2017.02.008. Epub 2017 Apr 26.
This study elucidated the temporal recurrence patterns of syncope in patients with frequent vasovagal syncope (VVS).
Understanding the temporal distribution of fainting spells in syncope patients may illuminate biological processes and inform decision making.
Patients from the POST 2 (Prevention of Syncope Trial 2) were included; all had VVS and fainted ≥4 times in the study year, providing ≥3 interevent intervals (IEIs). Only fainting spells separated by ≥1 day were included. IEI distributions were analyzed using Poisson modeling and cumulative sum distributions.
Twenty-four patients (5 males, 19 females; mean 33 years of age) had a total of 286 syncopal events and 262 IEIs, with a median 6 IEI. They resembled excluded subjects in age and sex but fainted more often in their lives (median: 57 vs. 13 fainting spells, respectively; p < 0.0001) and in the previous year (median: 23 vs. 3 fainting spells, respectively; p < 0.0001). Subjects had a median IEI duration of 8 (interquartile range: 4 to 19) days. The IEI distributions were fit well by Poisson models with a median r of 0.94 (95% confidence interval: 0.91 to 0.97). The patients' Poisson rate constant frequencies were 7 to 263 fainting spells/year with a median rate of 19 fainting spells/year. The modal syncope frequency was 10 to 15 fainting spells per year. Seven patients had biexponential distributions, and many patients fainted in clusters.
Patients with frequent VVS have fainting spells that occur randomly in time. Clusters of syncope occur, and in this population, there is a central tendency to 10 to 15 fainting spells per year. This provides a quantitative measure of frequency and predictability that may afford individualized treatment goals.
本研究阐明了频繁血管迷走性晕厥(VVS)患者晕厥的时间复发模式。
了解晕厥患者晕厥发作的时间分布情况可能阐明生物学过程并为决策提供信息。
纳入来自 POST 2 试验(晕厥预防试验 2)的患者;所有患者均为 VVS,且在研究年内晕厥发作≥4 次,提供≥3 次发作间期(IEI)。仅纳入间隔≥1 天的晕厥发作。使用泊松模型和累积和分布分析 IEI 分布。
24 例患者(5 例男性,19 例女性;平均年龄 33 岁)共发生 286 次晕厥事件和 262 次 IEI,IEI 中位数为 6。他们在年龄和性别上与排除的受试者相似,但一生中晕厥发作更为频繁(中位数:57 次与 13 次晕厥发作,分别;p<0.0001),前一年更为频繁(中位数:23 次与 3 次晕厥发作,分别;p<0.0001)。患者 IEI 持续时间中位数为 8 天(四分位距:4 至 19)。IEI 分布通过泊松模型拟合良好,中位数 r 为 0.94(95%置信区间:0.91 至 0.97)。患者泊松率常数频率为 7 至 263 次晕厥/年,中位数频率为 19 次晕厥/年。模式晕厥频率为每年 10 至 15 次晕厥。7 例患者存在双指数分布,许多患者呈簇状发作。
频繁发生 VVS 的患者其晕厥发作时间随机。晕厥发作呈簇状发生,在该人群中,每年 10 至 15 次晕厥发作具有集中趋势。这提供了频率和可预测性的定量测量,可能为个体化治疗目标提供依据。